Literature DB >> 1147591

Pharmacokinetic interpretation of blood levels and urinary excretion data for cefazolin and cephalothin after intravenous and intramuscular administration in humans.

E S Rattie, L J Ravin.   

Abstract

Blood levels of cefazolin and cephalothin were determined in two separate crossover studies in 20 healthy male adults, each after intravenous and intramuscular administration. Pharmacokinetic parameters were calculated from the intravenous data based upon a two-compartment open model. The rate constants controlling the distribution between the central and peripheral compartments, the overall elimination rate constants, the apparent volumes of distribution, and the fraction of the dose in the central and peripheral compartments were determined. The bioavailability was calculated to be 100% for cefazolin and cephalothin.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1147591      PMCID: PMC429190          DOI: 10.1128/AAC.7.5.606

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  12 in total

1.  Comparative serum levels and urinary recovery of cefazolin, cephaloridine, and cephalothin in man.

Authors:  M M Cahn; E J Levy; P Actor; J F Pauls
Journal:  J Clin Pharmacol       Date:  1974-01       Impact factor: 3.126

2.  Cefazolin, a new semisynthetic cephalosporin antibiotic. II. In vitro and in vivo antimicrobial activity.

Authors:  M Nishida; T Matsubara; T Murakawa; Y Mine; Y Yokota
Journal:  J Antibiot (Tokyo)       Date:  1970-03       Impact factor: 2.649

3.  Pharmacology of cefazolin in human volunteers.

Authors:  P Nicholas; B R Meyers; S Z Hirschman
Journal:  J Clin Pharmacol       Date:  1973 Aug-Sep       Impact factor: 3.126

4.  Cefazolin vs cephalothin and cephaloridine. A comparison of their clinical pharmacology.

Authors:  C Regamey; R C Gordon; W M Kirby
Journal:  Arch Intern Med       Date:  1974-03

5.  Pharmacologic study of cefazolin in volunteers.

Authors:  P De Schepper; C Harvengt; C Vranckx; B Boon; F Lamy
Journal:  J Clin Pharmacol New Drugs       Date:  1973 Feb-Mar

6.  Shortcomings in pharmacokinetic analysis by conceiving the body to exhibit properties of a single compartment.

Authors:  S Riegelman; J C Loo; M Rowland
Journal:  J Pharm Sci       Date:  1968-01       Impact factor: 3.534

7.  Pharmacokinetics of the cephalosporins in healthy volunteers and uremic patients.

Authors:  W M Kirby; J B De Maine; W S Serrill
Journal:  Postgrad Med J       Date:  1971-02       Impact factor: 2.401

8.  Serum and blood concentration of sodium cephalexin in man given single intramuscular and intravenous injections.

Authors:  P E Gower; C H Dash; C H O'Callaghan
Journal:  J Pharm Pharmacol       Date:  1973-05       Impact factor: 3.765

9.  Cefazolin, a new semisynthetic cephalosporin antibiotic. I. Synthesis and chemical properties of cefazolin.

Authors:  K Kariyone; H Harada; M Kurita; T Takano
Journal:  J Antibiot (Tokyo)       Date:  1970-03       Impact factor: 2.649

10.  Biological properties of three 3-heterocyclic-thiomethyl cephalosporin antibiotics.

Authors:  W E Wick; D A Preston
Journal:  Antimicrob Agents Chemother       Date:  1972-03       Impact factor: 5.191

View more
  12 in total

1.  Drug kinetics and artificial kidneys.

Authors:  T B Gibson; H A Nelson
Journal:  Clin Pharmacokinet       Date:  1977 Nov-Dec       Impact factor: 6.447

2.  Effects of general and local anesthesia on the pharmacokinetics of cefazolin in patients undergoing orthopedic surgery.

Authors:  W D Welch; J P Jantzen; K Johnson; R E Bawdon
Journal:  Antimicrob Agents Chemother       Date:  1985-05       Impact factor: 5.191

3.  Application of a Physiologically Based Pharmacokinetic Model to Predict Cefazolin and Cefuroxime Disposition in Obese Pregnant Women Undergoing Caesarean Section.

Authors:  Hanadi H Alrammaal; Khaled Abduljalil; Victoria Hodgetts Morton; R Katie Morris; John F Marriott; Hsu P Chong; Hannah K Batchelor
Journal:  Pharmaceutics       Date:  2022-05-30       Impact factor: 6.525

4.  New in vitro model to study the effect of antibiotic concentration and rate of elimination on antibacterial activity.

Authors:  S Grasso; G Meinardi; I de Carneri; V Tamassia
Journal:  Antimicrob Agents Chemother       Date:  1978-04       Impact factor: 5.191

5.  Pharmacological study of cefazolin during intermittent and continuous infusion: a crossover investigation in humans.

Authors:  J P Thys; B Vanderkelen; J Klastersky
Journal:  Antimicrob Agents Chemother       Date:  1976-09       Impact factor: 5.191

6.  Quantitation of antibiotics by high-pressure liquid chromatography: cephalothin.

Authors:  I Nilsson-Ehle; T T Yoshikawa; M C Schotz; L B Guze
Journal:  Antimicrob Agents Chemother       Date:  1978-02       Impact factor: 5.191

7.  Pirbenicillin: pharmacokinetic parameters in mice.

Authors:  A R English; D Girard; J A Retsema
Journal:  Antimicrob Agents Chemother       Date:  1976-09       Impact factor: 5.191

8.  Correction of permeability with pore radius of tight junctions in Caco-2 monolayers improves the prediction of the dose fraction of hydrophilic drugs absorbed by humans.

Authors:  Ryoichi Saitoh; Kiyohiko Sugano; Noriyuki Takata; Tatsuhiko Tachibana; Atsuko Higashida; Yoshiaki Nabuchi; Yoshinori Aso
Journal:  Pharm Res       Date:  2004-05       Impact factor: 4.200

9.  Clinical on-site monitoring of ß-lactam antibiotics for a personalized antibiotherapy.

Authors:  R Bruch; C Chatelle; A Kling; B Rebmann; S Wirth; S Schumann; W Weber; C Dincer; G Urban
Journal:  Sci Rep       Date:  2017-06-09       Impact factor: 4.379

10.  PBPK Modeling Approach to Predict the Behavior of Drugs Cleared by Kidney in Pregnant Subjects and Fetus.

Authors:  Ke Xu Szeto; Maxime Le Merdy; Benjamin Dupont; Michael B Bolger; Viera Lukacova
Journal:  AAPS J       Date:  2021-06-24       Impact factor: 4.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.